go 6976 and tanespimycin

go 6976 has been researched along with tanespimycin in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bilter, GK; Dias, J; Huang, Z; Keon, BH; Lamerdin, J; MacDonald, ML; Michnick, SW; Minami, T; Owens, S; Shang, Z; Westwick, JK; Yu, H	1
Ahmad, G; Bailey, TA; Band, H; Band, V; Bielecki, TA; George, M; Kelly, DL; Luan, H; Mohapatra, B; Natarajan, A; Raja, SM; Tom, E	1

Other Studies

2 other study(ies) available for go 6976 and tanespimycin

Article	Year
Identifying off-target effects and hidden phenotypes of drugs in human cells. Nature chemical biology, 2006, Volume: 2, Issue:6 Topics: Bacterial Proteins; Cell Line; Cell Proliferation; Cluster Analysis; Drug Design; Drug Evaluation, Preclinical; Genetics; Humans; Luminescent Proteins; Molecular Structure; Phenotype; Recombinant Fusion Proteins; Signal Transduction; Structure-Activity Relationship	2006
A kinase inhibitor screen reveals protein kinase C-dependent endocytic recycling of ErbB2 in breast cancer cells. The Journal of biological chemistry, 2014, Oct-31, Volume: 289, Issue:44 Topics: Antineoplastic Agents; Benzoquinones; Breast Neoplasms; Carbazoles; Carcinogenesis; Cell Line, Tumor; Drug Screening Assays, Antitumor; Endocytosis; Endosomes; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Feedback, Physiological; Female; Humans; Indoles; Lactams, Macrocyclic; MAP Kinase Signaling System; Phosphorylation; Protein Kinase C-alpha; Protein Kinase C-delta; Protein Kinase Inhibitors; Protein Processing, Post-Translational; Protein Transport; Receptor, ErbB-2	2014

Article

Year

Identifying off-target effects and hidden phenotypes of drugs in human cells.

Nature chemical biology, 2006, Volume: 2, Issue:6

Topics: Bacterial Proteins; Cell Line; Cell Proliferation; Cluster Analysis; Drug Design; Drug Evaluation, Preclinical; Genetics; Humans; Luminescent Proteins; Molecular Structure; Phenotype; Recombinant Fusion Proteins; Signal Transduction; Structure-Activity Relationship

2006

A kinase inhibitor screen reveals protein kinase C-dependent endocytic recycling of ErbB2 in breast cancer cells.

The Journal of biological chemistry, 2014, Oct-31, Volume: 289, Issue:44

Topics: Antineoplastic Agents; Benzoquinones; Breast Neoplasms; Carbazoles; Carcinogenesis; Cell Line, Tumor; Drug Screening Assays, Antitumor; Endocytosis; Endosomes; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Feedback, Physiological; Female; Humans; Indoles; Lactams, Macrocyclic; MAP Kinase Signaling System; Phosphorylation; Protein Kinase C-alpha; Protein Kinase C-delta; Protein Kinase Inhibitors; Protein Processing, Post-Translational; Protein Transport; Receptor, ErbB-2

2014